The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...
New treatment option combines proven efficacy and established safety profile of buprenorphine with a novel delivery system that adds convenience and flexibility Endo Pharmaceuticals Inc., a subsidiary ...
There is a black market for buprenorphin, an approved drug for opioid addiction. This is a Kaiser Health News story. Months in prison didn’t rid Daryl of his addiction to opioids. “Before I left the ...
(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's ...
SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that its co-developer, Chemo Research SL, through its ...
U.S. regulators have approved the first generic version of an under-the-tongue film for treating opioid addiction. The Food and Drug Administration on Thursday approved a generic version of Suboxone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results